» Articles » PMID: 18283995

Long-term Outcome After Acute Kidney Injury in Critically-ill Patients

Overview
Journal Acta Clin Belg
Specialty General Medicine
Date 2008 Feb 21
PMID 18283995
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Assessment of short-term outcome in critically-ill patients who develop acute kidney injury (AKI) may underestimate the true burden of disease. It is important to focus on long-term survival, renal recovery and quality of life beyond hospital discharge. Although the majority of critically-ill patients with AKI die during hospital stay, there is only a minor increase in mortality after hospital discharge among AKI patients treated in the intensive care unit (ICU). Estimates of mortality rates at 1 year following hospital discharge range from 57% to 78% with an absolute difference between hospital mortality and 1-year mortality ranging from 4% to 18%. Renal recovery is another important measure of outcome since chronic renal replacement therapy (RRT) does not only significantly affect health-related quality of life (HRQoL), it is also costly. Fortunately, renal recovery occurs in most AKI survivors leading to independence of RRT at 1 year following hospital discharge. Potential factors associated with reduced recovery of renal function are female sex, high comorbidity, older age, a parenchymal aetiology of AKI, late initiation of RRT, and use of intermittent haemodialysis (IHD). HRQoL in survivors of critical illness and severe AKI is perceived as acceptable and good, despite the fact that HRQoL scores are lower than these of the general population.

Citing Articles

Return to work after hospitalization for sepsis: a nationwide, registry-based cohort study.

Skei N, Moe K, Nilsen T, Aasdahl L, Prescott H, Damas J Crit Care. 2023; 27(1):443.

PMID: 37968648 PMC: 10652599. DOI: 10.1186/s13054-023-04737-7.


[Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)].

Ballesteros Sanz M, Hernandez-Tejedor A, Estella A, Jimenez Rivera J, Gonzalez de Molina Ortiz F, Sandiumenge Camps A Med Intensiva (Engl Ed). 2020; 44(6):371-388.

PMID: 32360034 PMC: 7142677. DOI: 10.1016/j.medin.2020.04.001.


Enhanced proliferation and differentiation of HO-1 gene-modified bone marrow-derived mesenchymal stem cells in the acute injured kidney.

Liu N, Wang H, Han G, Cheng J, Hu W, Zhang J Int J Mol Med. 2018; 42(2):946-956.

PMID: 29749549 PMC: 6034926. DOI: 10.3892/ijmm.2018.3670.


Organ support therapy in the intensive care unit and return to work: a nationwide, register-based cohort study.

Riddersholm S, Christensen S, Kragholm K, Christiansen C, Rasmussen B Intensive Care Med. 2018; 44(4):418-427.

PMID: 29616288 DOI: 10.1007/s00134-018-5157-1.


Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study.

Oeyen S, De Corte W, Benoit D, Annemans L, Dhondt A, Vanholder R Crit Care. 2015; 19:289.

PMID: 26250830 PMC: 4527359. DOI: 10.1186/s13054-015-1004-8.